MARKET

ATAI

ATAI

Atai Beckley Inc
NASDAQ
3.970
-0.030
-0.75%
After Hours: 3.920 -0.05 -1.26% 19:23 01/08 EST
OPEN
3.990
PREV CLOSE
4.000
HIGH
4.090
LOW
3.900
VOLUME
3.37M
TURNOVER
--
52 WEEK HIGH
6.75
52 WEEK LOW
1.150
MARKET CAP
1.44B
P/E (TTM)
-4.8795
1D
5D
1M
3M
1Y
5Y
1D
Advancing Neuropsychiatric Pipeline and Clear 2026 Milestones Underpin Buy Rating on ATAI Life Sciences
TipRanks · 18h ago
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’
TipRanks · 20h ago
AtaiBeckley Joins NASDAQ Biotechnology Index
Reuters · 20h ago
ATAIBECKLEY PROVIDES UPDATE AND OUTLOOK FOR 2026 AHEAD OF J.P. MORGAN HEALTHCARE CONFERENCE
Reuters · 20h ago
ATAI BECKLEY NV - ATAIBECKLEY ANTICIPATES TOPLINE DATA FROM VLS-01 TRIAL IN H2’26
Reuters · 20h ago
AtaiBeckley: A Massive Market Opportunity But Execution Risk Exists
Seeking Alpha · 2d ago
FDA Lifts Hold On GH Research's Depression Drug Trial After Two Years
Benzinga · 3d ago
Weekly Report: what happened at ATAI last week (1229-0102)?
Weekly Report · 3d ago
More
About ATAI
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.

Webull offers Atai Beckley NV stock information, including NASDAQ: ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.